BWX Technologies, Inc.(BWXT)— Stock Profile, AI Score & Financials
Industrials · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
BWX Technologies, Inc. (BWXT) stock profile, AI quality score, and SEC EDGAR financial data, a Industrials sector company. 13F Pro's AI-powered ranking engine scores BWXT at 63.8/100 on a 32-signal composite quality model, placing it at rank #587 of 2,961 stocks — the top 25% of the AI-ranked universe. BWXT scores in the top quartile across balance sheet strength (76.0). Areas of concern include institutional flow (21.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), BWX Technologies, Inc. reports quarterly revenue of $901.6M, net income of $89.0M, an operating margin of 12.7%. Top institutional holders of BWXT by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. BWXT trades on the NYSE exchange and files with the SEC under CIK 1486957. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BWXT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BWX Technologies, Inc. directly from SEC EDGAR.
AI Quality Score
63.8/100
AI Rank
#587
Revenue
$901.6M
Net Income
$89.0M
Free Cash Flow
$115.0M
Operating Margin
12.7%
BWXT key financials by period
BWX Technologies, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$3.2B
$328.9M
12.7%
FY 2024
10-K
$2.7B
$281.9M
14.1%
FY 2023
10-K
$2.5B
$245.8M
15.3%
FY 2022
10-K
$2.2B
$238.2M
15.6%
FY 2021
10-K
$2.1B
$305.9M
16.3%
FY 2020
10-K
$2.1B
$278.7M
16.9%
Institutions holding BWXT
Institutional investors reporting a position in BWX Technologies, Inc. on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-08-03 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Revenue grew 18.0% YoY to $901.6M as Commercial Operations surged 71.7% on the Kinectrics acquisition and higher service work, while Government Operations grew a modest 2.1% and its margin compressed to 17.6% from 18.6%.
Biggest Revenue Drivers
Government Operations$601.3M+2.1% YoY
Increase primarily due to contributions from enrichment operations
Commercial Operations$302.5M+71.7% YoY
Kinectrics acquisition added $68.3M; higher on-site inspection, maintenance, modification and refurbishment work of $31.8M and fuel handling/engineering/parts of $19.6M
Biggest Revenue Drivers
Total revenue: $901.6M+18.0% YoY
Government Operations$601.3M+2.1% YoY
Increase primarily due to contributions from enrichment operations
Within Government Operations
Nuclear Components and Fuel$472.5M
Commercial Operations$302.5M+71.7% YoY
Kinectrics acquisition added $68.3M; higher on-site inspection, maintenance, modification and refurbishment work of $31.8M and fuel handling/engineering/parts of $19.6M
Within Commercial Operations
Nuclear Services and Engineering$173.4M
Largest Expense Items
Cost of operations$699.3M
Selling, general and administrative expenses$108.4M
Research and development costs$4.2M
Margins: Government Operations operating margin fell to 17.6% of revenue from 18.6% due to favorable contract adjustments in the prior-year period; Commercial Operations margin more than doubled to 8.0% from 3.9% on revenue growth and a favorable product mix shift.
Watch Items from the Filing
Backlog grew to $8,398.1M at June 30, 2026 from $7,261M at year-end 2025, including $2,256.4M of unfunded U.S. Government backlog.
Sales to the U.S. Government accounted for approximately 87% of Government Operations segment revenue in the quarter.
Large utility customers accounted for approximately 54% of Commercial Operations segment revenue, down from 60% a year ago.
On July 31, 2026, BWXT agreed to sell its medical business (BWXT Medical and Kinectrics' stable isotope business) to Nordic Capital in a deal valued up to $800M, retaining a minority interest.
Acquisition of Precision Components Group closed July 1, 2026, expanding U.S. heavy-manufacturing and commercial nuclear production capacity within Commercial Operations.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
